Page last updated: 2024-08-23

phenyl acetate and celecoxib

phenyl acetate has been researched along with celecoxib in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's3 (42.86)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Alvaro-Gracia, JM1
Bertelli, JA; Calixto, JB; Campos, MM; Ferreira, J; Rodrigues-Filho, R; Santos, AR1
Fischer, SM; Kline, K; Riedel, SB; Sanders, BG1
Danino, D; Kesselman, E; Magdassi, S; Margulis-Goshen, K1
Hamatsu, Y; Kataoka, M; Masaoka, Y; Sakuma, S; Yamashita, S; Yano, K1
Gordon, V; Magdassi, S; Marom, G1
Abdelhady, SA; Abdelmawgoud, EM; Al-Shafie, TA; Ali, MA; El-Mas, MM; Yacout, DM1

Reviews

1 review(s) available for phenyl acetate and celecoxib

ArticleYear
Licofelone--clinical update on a novel LOX/COX inhibitor for the treatment of osteoarthritis.
    Rheumatology (Oxford, England), 2004, Volume: 43 Suppl 1

    Topics: Acetates; Aspirin; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Combinations; Gastrointestinal Diseases; Humans; Isoenzymes; Lipoxygenase Inhibitors; Long-Term Care; Membrane Proteins; Osteoarthritis; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Pyrroles; Sulfonamides

2004

Other Studies

6 other study(ies) available for phenyl acetate and celecoxib

ArticleYear
Pharmacological characterisation of the rat brachial plexus avulsion model of neuropathic pain.
    Brain research, 2004, Aug-27, Volume: 1018, Issue:2

    Topics: Acetates; Amines; Analgesics; Analysis of Variance; Animals; Brachial Plexus; Brachial Plexus Neuropathies; Celecoxib; Clonidine; Cyclohexanecarboxylic Acids; Disease Models, Animal; Gabapentin; gamma-Aminobutyric Acid; Ketamine; Lidocaine; Male; Morphine; Neuralgia; Nociceptors; Pain Measurement; Pain Threshold; Pyrazoles; Radiculopathy; Rats; Rats, Wistar; Sulfonamides

2004
Vitamin E analog, alpha-tocopherol ether-linked acetic acid analog, alone and in combination with celecoxib, reduces multiplicity of ultraviolet-induced skin cancers in mice.
    Anti-cancer drugs, 2008, Volume: 19, Issue:2

    Topics: Acetates; Administration, Inhalation; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Celecoxib; Cyclooxygenase Inhibitors; Liposomes; Mice; Mice, Hairless; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Neoplasms, Squamous Cell; Pyrazoles; Radiation Dosage; Skin; Skin Neoplasms; Sulfonamides; Time Factors; Tocopherols; Treatment Outcome; Ultraviolet Rays

2008
Formation of celecoxib nanoparticles from volatile microemulsions.
    International journal of pharmaceutics, 2010, Jun-30, Volume: 393, Issue:1-2

    Topics: Acetates; Butanols; Celecoxib; Chemistry, Pharmaceutical; Cryoelectron Microscopy; Cyclooxygenase 2 Inhibitors; Drug Carriers; Drug Compounding; Electric Conductivity; Emulsions; Glycyrrhizic Acid; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Phosphatidylcholines; Powders; Pyrazoles; Solubility; Sulfonamides; Surface-Active Agents; Technology, Pharmaceutical; Volatilization; Water

2010
Assessment of absorption potential of poorly water-soluble drugs by using the dissolution/permeation system.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2013, Volume: 85, Issue:3 Pt B

    Topics: Absorption; Acetates; Administration, Oral; Animals; Area Under Curve; Caco-2 Cells; Celecoxib; Chemistry, Pharmaceutical; Cyclopropanes; Humans; Indoles; Intestinal Absorption; Male; Permeability; Phenylcarbamates; Pyrazoles; Quinolines; Rats; Rats, Wistar; Solubility; Sulfides; Sulfonamides; Technology, Pharmaceutical; Tosyl Compounds; Water

2013
Formation of hydrophilic nanofibers from nanoemulsions through electrospinning.
    International journal of pharmaceutics, 2015, Jan-15, Volume: 478, Issue:1

    Topics: Acetates; Celecoxib; Emulsions; Hexoses; Hydrophobic and Hydrophilic Interactions; Nanocomposites; Nanofibers; Nanoparticles; Particle Size; Polysorbates; Polyvinyl Alcohol; Solubility; Solvents; Surface-Active Agents

2015
Montelukast potentiates the antiinflammatory effect of NSAIDs in the rat paw formalin model and simultaneously minimizes the risk of gastric damage.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2021, Volume: 70, Issue:9

    Topics: Acetates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2; Cyclopropanes; Diclofenac; Formaldehyde; Inflammation; Male; Nitric Oxide Synthase Type II; Quinolines; Rats; Rats, Wistar; Risk; Signal Transduction; Stomach; Sulfides

2021